Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LOMITAPIDE for Coronary artery disease: Side Effects & Safety Data

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

There are 7 adverse event reports in the FDA FAERS database where LOMITAPIDE was used for Coronary artery disease.

Most Reported Side Effects for LOMITAPIDE

Side Effect Reports % Deaths Hosp.
Diarrhoea 1,071 28.3% 4 77
Therapy cessation 828 21.9% 4 108
Weight decreased 828 21.9% 1 58
Nausea 567 15.0% 13 69
Abdominal pain upper 280 7.4% 0 30
Flatulence 244 6.5% 2 11
Abdominal discomfort 228 6.0% 1 15
Vomiting 211 5.6% 0 34
Off label use 206 5.5% 2 23
Fatigue 200 5.3% 0 16
Drug dose omission 185 4.9% 1 15
Inappropriate schedule of drug administration 184 4.9% 1 15
Hepatic enzyme increased 183 4.8% 0 13
Abdominal pain 172 4.6% 13 31
Constipation 165 4.4% 1 22

Other Indications for LOMITAPIDE

Type iia hyperlipidaemia (3,314) Product used for unknown indication (244) Hypercholesterolaemia (63) Hyperlipidaemia (43) Low density lipoprotein (33) Low density lipoprotein abnormal (33) Blood cholesterol increased (15) Dyslipidaemia (15) Familial hypertriglyceridaemia (11) Low density lipoprotein increased (8)

Other Drugs Used for Coronary artery disease

ASPIRIN (2,758) CLOPIDOGREL BISULFATE (1,584) EVOLOCUMAB (1,266) ATORVASTATIN (891) RIVAROXABAN (847) DILTIAZEM (664) ROSUVASTATIN (600) TICAGRELOR (520) QUINAPRIL (511) AMLODIPINE (486)

Related Pages

LOMITAPIDE Full Profile All Coronary artery disease Drugs LOMITAPIDE Demographics LOMITAPIDE Timeline